Tatva Chintan Pharma Chem Limited (NSE:TATVA)
India
· Delayed Price · Currency is INR 1,294.30
-36.10 (-2.71%)
Apr 29, 2026, 3:29 PM IST
Tatva Chintan Pharma Chem Revenue
Tatva Chintan Pharma Chem had revenue of 1.31B INR in the quarter ending December 31, 2025, with 52.90% growth. This brings the company's revenue in the last twelve months to 4.80B, up 28.53% year-over-year. In the fiscal year ending March 31, 2025, Tatva Chintan Pharma Chem had annual revenue of 3.83B, down -2.74%.
Revenue (ttm)
4.80B
Revenue Growth
+28.53%
P/S Ratio
6.49
Revenue / Employee
7.06M
Employees
679
Market Cap
31.12B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NOCIL | 13.12B |
| Fineotex Chemical | 5.78B |
| Jubilant Agri and Consumer Products | 18.04B |
| Rossari Biotech | 22.91B |
| Advanced Enzyme Technologies | 7.10B |
| Savita Oil Technologies | 41.44B |
| Sirca Paints India | 4.59B |
| Veedol Corporation | 20.94B |